Current status of lymph node-positive prostate cancer

Incidence and predictors of outcome

Gregory P Swanson, Ian M. Thompson, Joseph W Basler

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

In early surgical series, the incidence of positive lymph nodes in patients with prostate cancer was approximately 40%. In the modern era of screening and improved patient selection, the incidence is now <10%, although most series excluded patients with higher risk disease. The risk of having positive lymph nodes is influenced by disease stage, prostate-specific antigen level, and tumor grade and by the aggressiveness of lymph node dissection. Many of the same factors predict the outcome of these patients. Although the percentage of patients with positive lymph nodes has declined, there remain significant numbers of patients with lymph node-positive prostate cancer, and it remains a therapeutic dilemma.

Original languageEnglish (US)
Pages (from-to)439-450
Number of pages12
JournalCancer
Volume107
Issue number3
DOIs
StatePublished - Aug 1 2006

Fingerprint

Prostatic Neoplasms
Lymph Nodes
Incidence
Prostate-Specific Antigen
Lymph Node Excision
Patient Selection
Neoplasms
Therapeutics

Keywords

  • DNA content
  • Hormone-deprivation therapy
  • Lymph node status
  • Prostate-specific antigen
  • Prostatectomy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Current status of lymph node-positive prostate cancer : Incidence and predictors of outcome. / Swanson, Gregory P; Thompson, Ian M.; Basler, Joseph W.

In: Cancer, Vol. 107, No. 3, 01.08.2006, p. 439-450.

Research output: Contribution to journalArticle

Swanson, Gregory P ; Thompson, Ian M. ; Basler, Joseph W. / Current status of lymph node-positive prostate cancer : Incidence and predictors of outcome. In: Cancer. 2006 ; Vol. 107, No. 3. pp. 439-450.
@article{c35aef477410415ea04c929944b346dc,
title = "Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome",
abstract = "In early surgical series, the incidence of positive lymph nodes in patients with prostate cancer was approximately 40{\%}. In the modern era of screening and improved patient selection, the incidence is now <10{\%}, although most series excluded patients with higher risk disease. The risk of having positive lymph nodes is influenced by disease stage, prostate-specific antigen level, and tumor grade and by the aggressiveness of lymph node dissection. Many of the same factors predict the outcome of these patients. Although the percentage of patients with positive lymph nodes has declined, there remain significant numbers of patients with lymph node-positive prostate cancer, and it remains a therapeutic dilemma.",
keywords = "DNA content, Hormone-deprivation therapy, Lymph node status, Prostate-specific antigen, Prostatectomy",
author = "Swanson, {Gregory P} and Thompson, {Ian M.} and Basler, {Joseph W}",
year = "2006",
month = "8",
day = "1",
doi = "10.1002/cncr.22034",
language = "English (US)",
volume = "107",
pages = "439--450",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Current status of lymph node-positive prostate cancer

T2 - Incidence and predictors of outcome

AU - Swanson, Gregory P

AU - Thompson, Ian M.

AU - Basler, Joseph W

PY - 2006/8/1

Y1 - 2006/8/1

N2 - In early surgical series, the incidence of positive lymph nodes in patients with prostate cancer was approximately 40%. In the modern era of screening and improved patient selection, the incidence is now <10%, although most series excluded patients with higher risk disease. The risk of having positive lymph nodes is influenced by disease stage, prostate-specific antigen level, and tumor grade and by the aggressiveness of lymph node dissection. Many of the same factors predict the outcome of these patients. Although the percentage of patients with positive lymph nodes has declined, there remain significant numbers of patients with lymph node-positive prostate cancer, and it remains a therapeutic dilemma.

AB - In early surgical series, the incidence of positive lymph nodes in patients with prostate cancer was approximately 40%. In the modern era of screening and improved patient selection, the incidence is now <10%, although most series excluded patients with higher risk disease. The risk of having positive lymph nodes is influenced by disease stage, prostate-specific antigen level, and tumor grade and by the aggressiveness of lymph node dissection. Many of the same factors predict the outcome of these patients. Although the percentage of patients with positive lymph nodes has declined, there remain significant numbers of patients with lymph node-positive prostate cancer, and it remains a therapeutic dilemma.

KW - DNA content

KW - Hormone-deprivation therapy

KW - Lymph node status

KW - Prostate-specific antigen

KW - Prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=33746309710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746309710&partnerID=8YFLogxK

U2 - 10.1002/cncr.22034

DO - 10.1002/cncr.22034

M3 - Article

VL - 107

SP - 439

EP - 450

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -